{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"null","columns":[{"gene":"","key":"population-e15cd6a100446898dfa3","label":"Null syndrome","mondoId":"MONDO:0017225","onsetQualifier":null,"originColumnKey":"MONDO:0017225/ORPHA:280234","originalViews":[{"key":"MONDO:0017225/ORPHA:280234","label":"Null syndrome","scopeLabel":"ORPHA:280234","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0927a8b4a7503a975cf1d0cfbd7452950a6a570a363d604e42338a053f29c4b9","15766992545b6718504fa19ae4ddc282c7ca216bb8a46d45062ccdcff8d9a5b3","22a1972214cdb8ab73d52906a7ab16910b5df451a2c1e908f6bd5523454de34b","2a35f9cc41529d8b7569e8cbf6e223c89d9ef1780057415c2995f90cbdd47c15","2e4b13d13009dd8386287bf4c60dbfbd238d389e651ea28f252f619aa936d76a","4470fc611826693451971fc092201a9df5eaec597484f96d679906e472b36424","4bcc4bdec49cc5ba9c0a150ecfe75307eebca1fc4e961aa06d6fba61864c27b7","653b4948a80a80210a3925cc13a0da105a402c80887bca1374c06d160c2cdbbf","6a1f198f9d00d930b0b59438d87af346d7246adc3ab9c2faa253d8afc0b0187a","a7f3cdf831ec5ce5301911f7b6bd9c7ebdc3cd267527f03f36edbc694c2029c5","ba6467203afdcaf5237e0aeaf0975b7c701b383f955b740cab44e938eed8db88","c20bcd688ea7d4d2790d833facc605adebfb492aa870233b2e7473140b2cffb9","c42f0968416ccc998cfecdc1a712a3d6b86b9709410f4cddc6ddcdc603efcd0e","ce72775e6f3f13b775a3898b2eb566b44c5d4eaaa7820f5c728c509faff8b086","ee2f166e27c67ecfe9826f3780e32be4874f825937ad3fb7d548434d11fb99c3"],"recordQualifiers":{},"scopeLabel":"ORPHA:280234","sourceIds":["ORPHA:280234"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e15cd6a100446898dfa3"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001317","HP:0003134","HP:0001251","HP:0003429","HP:0000762","HP:0007108","HP:0001288"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"orphanet":15}},"features":[{"hpoId":"HP:0001317","label":"Abnormal cerebellum morphology","primary":true},{"hpoId":"HP:0003134","label":"Abnormality of peripheral nerve conduction","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0003429","label":"CNS hypomyelination","primary":true},{"hpoId":"HP:0000762","label":"Decreased nerve conduction velocity","primary":true},{"hpoId":"HP:0007108","label":"Demyelinating peripheral neuropathy","primary":true},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":true},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0002342","label":"Moderate intellectual disability","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0011096","label":"Peripheral demyelination","primary":false},{"hpoId":"HP:0007020","label":"Progressive spastic paraplegia","primary":false},{"hpoId":"HP:0002478","label":"Progressive spastic quadriplegia","primary":false}],"ledeHtml":"The PLP1 null syndrome is part of the Pelizaeus-Merzbacher disease (PMD) spectrum and is characterized by mild PMD features associated with demyelinating peripheral neuropathy.","mondoId":"MONDO:0017225","node":{"canonicalSlug":"null","comparisons":[{"documentSha256":"c25393f3845210f6a1e5f8f8ee849a3038ad6f06279f89ec3c0e7c9c4b511a07","key":"legacy-pelizaeus-merzbacher-disease","kind":"legacy","label":"Pelizaeus-Merzbacher spectrum disorder","memberIds":["MONDO:0010714","MONDO:0017221","MONDO:0017222","MONDO:0017223","MONDO:0017224","MONDO:0017225"],"mondoId":"MONDO:0010714","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pelizaeus-merzbacher-disease.c25393f3845210f6a1e5f8f8ee849a3038ad6f06279f89ec3c0e7c9c4b511a07.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"null syndrome","paragraphs":["The PLP1 null syndrome is part of the Pelizaeus-Merzbacher disease (PMD) spectrum and is characterized by mild PMD features associated with demyelinating peripheral neuropathy."],"scope":"exact","source":"MONDO","upstream":"Orphanet:280234","url":"https://monarchinitiative.org/MONDO:0017225"},"ownColumnKeys":["population-e15cd6a100446898dfa3"],"publication":"published","relationships":[{"kind":"parent","label":"Pelizaeus-Merzbacher spectrum disorder","mondoId":"MONDO:0010714","slug":"pelizaeus-merzbacher-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17292"}],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"The actual narrative and PLP1 reference identify PLP1 null syndrome. Clarify the ambiguous display title without changing its route or MONDO ID.","sources":["https://www.ncbi.nlm.nih.gov/books/NBK1182/"],"originalNarrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"null syndrome","paragraphs":["The null syndrome is part of the Pelizaeus-Merzbacher disease (PMD) spectrum and is characterized by mild PMD features associated with demyelinating peripheral neuropathy."],"scope":"exact","source":"MONDO","upstream":"Orphanet:280234","url":"https://monarchinitiative.org/MONDO:0017225"},"claimHolds":[]}},"records":[{"frequencyKind":"range","key":"0927a8b4a7503a975cf1d0cfbd7452950a6a570a363d604e42338a053f29c4b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002342","is_excluded":false,"label":"Moderate intellectual disability","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"15766992545b6718504fa19ae4ddc282c7ca216bb8a46d45062ccdcff8d9a5b3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007020","is_excluded":false,"label":"Progressive spastic paraplegia","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"22a1972214cdb8ab73d52906a7ab16910b5df451a2c1e908f6bd5523454de34b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003134","is_excluded":false,"label":"Abnormality of peripheral nerve conduction","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"2a35f9cc41529d8b7569e8cbf6e223c89d9ef1780057415c2995f90cbdd47c15","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":true,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e4b13d13009dd8386287bf4c60dbfbd238d389e651ea28f252f619aa936d76a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4470fc611826693451971fc092201a9df5eaec597484f96d679906e472b36424","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001317","is_excluded":false,"label":"Abnormal cerebellum morphology","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4bcc4bdec49cc5ba9c0a150ecfe75307eebca1fc4e961aa06d6fba61864c27b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"653b4948a80a80210a3925cc13a0da105a402c80887bca1374c06d160c2cdbbf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000762","is_excluded":false,"label":"Decreased nerve conduction velocity","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6a1f198f9d00d930b0b59438d87af346d7246adc3ab9c2faa253d8afc0b0187a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003429","is_excluded":false,"label":"CNS hypomyelination","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a7f3cdf831ec5ce5301911f7b6bd9c7ebdc3cd267527f03f36edbc694c2029c5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011096","is_excluded":false,"label":"Peripheral demyelination","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba6467203afdcaf5237e0aeaf0975b7c701b383f955b740cab44e938eed8db88","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c20bcd688ea7d4d2790d833facc605adebfb492aa870233b2e7473140b2cffb9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007108","is_excluded":false,"label":"Demyelinating peripheral neuropathy","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c42f0968416ccc998cfecdc1a712a3d6b86b9709410f4cddc6ddcdc603efcd0e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce72775e6f3f13b775a3898b2eb566b44c5d4eaaa7820f5c728c509faff8b086","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002478","is_excluded":false,"label":"Progressive spastic quadriplegia","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee2f166e27c67ecfe9826f3780e32be4874f825937ad3fb7d548434d11fb99c3","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:280234","disease_name":"Null syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:280234","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017225\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:280234</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1182/\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>The PLP1 null syndrome is part of the Pelizaeus-Merzbacher disease (PMD) spectrum and is characterized by mild PMD features associated with demyelinating peripheral neuropathy.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017225\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"null","sourceDocuments":[{"name":"MONDO: null syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017225"}],"sourceNote":"","synonyms":["Pelizaeus-Merzbacher disease, null syndrome","PLP1 null syndrome"],"takeawayHtml":"","title":"PLP1 null syndrome"},"schemaVersion":1}
